385 related articles for article (PubMed ID: 25392238)
21. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry.
Ismaiel OA; Zhang T; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3303-16. PubMed ID: 21056019
[TBL] [Abstract][Full Text] [Related]
22. Simple and efficient digestion of a monoclonal antibody in serum using pellet digestion: comparison with traditional digestion methods in LC-MS/MS bioanalysis.
Yuan L; Arnold ME; Aubry AF; Ji QC
Bioanalysis; 2012 Dec; 4(24):2887-96. PubMed ID: 23244280
[TBL] [Abstract][Full Text] [Related]
23. LC-MS bioanalysis of intact proteins and peptides.
Kang L; Weng N; Jian W
Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
[TBL] [Abstract][Full Text] [Related]
24. An automation-assisted generic approach for biological sample preparation and LC-MS/MS method validation.
Zhang J; Wei S; Ayres DW; Smith HT; Tse FL
Bioanalysis; 2011 Sep; 3(17):1975-86. PubMed ID: 21899506
[TBL] [Abstract][Full Text] [Related]
25. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.
Wickremsinhe ER; Ackermann BL; Chaudhary AK
Rapid Commun Mass Spectrom; 2005; 19(1):47-56. PubMed ID: 15570573
[TBL] [Abstract][Full Text] [Related]
26. Critical considerations for immunocapture enrichment LC-MS bioanalysis of protein therapeutics and biomarkers.
Zhao Y; Gu H; Zheng N; Zeng J
Bioanalysis; 2018 Jul; 10(13):987-995. PubMed ID: 29972311
[TBL] [Abstract][Full Text] [Related]
27. Quantitation of therapeutic proteins following direct trypsin digestion of dried blood spot samples and detection by LC-MS-based bioanalytical methods in drug discovery.
Sleczka BG; D'Arienzo CJ; Tymiak AA; Olah TV
Bioanalysis; 2012 Jan; 4(1):29-40. PubMed ID: 22191592
[TBL] [Abstract][Full Text] [Related]
28. Guanidinated protein internal standard for immunoaffinity-liquid chromatography/tandem mass spectrometry quantitation of protein therapeutics.
Yang W; Kernstock R; Simmons N; Alak A
Rapid Commun Mass Spectrom; 2014 Jul; 28(13):1489-500. PubMed ID: 24861599
[TBL] [Abstract][Full Text] [Related]
29. Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry.
van den Broek I; Sparidans RW; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):1-22. PubMed ID: 18701357
[TBL] [Abstract][Full Text] [Related]
30. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.
Sennbro CJ; Knutsson M; van Amsterdam P; Timmerman P
Bioanalysis; 2011 Nov; 3(21):2393-9. PubMed ID: 22074281
[TBL] [Abstract][Full Text] [Related]
31. Dried blood spots as a sampling technique for the quantitative determination of guanfacine in clinical studies.
Li Y; Henion J; Abbott R; Wang P
Bioanalysis; 2011 Nov; 3(22):2501-14. PubMed ID: 22122599
[TBL] [Abstract][Full Text] [Related]
32. 'Large Meets Small': connecting the bioanalytical community around peptide and protein bioanalysis with LC-MS(/MS).
Timmerman P; Lausecker B; Barosso B; van Amsterdam P; Luedtke S; Dijksman J
Bioanalysis; 2012 Mar; 4(6):627-31. PubMed ID: 22452251
[TBL] [Abstract][Full Text] [Related]
33. Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology.
van Nuland M; Rosing H; Schellens JHM; Beijnen JH
Biomed Chromatogr; 2020 Jan; 34(1):e4623. PubMed ID: 31215049
[TBL] [Abstract][Full Text] [Related]
34. Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry.
Berna M; Ackermann B
Anal Chem; 2009 May; 81(10):3950-6. PubMed ID: 19388669
[TBL] [Abstract][Full Text] [Related]
35. Reliable procedures to evaluate and repair crosstalk for bioanalytical MS/MS assays.
Morin LP; Mess JN; Furtado M; Garofolo F
Bioanalysis; 2011 Feb; 3(3):275-83. PubMed ID: 21320048
[TBL] [Abstract][Full Text] [Related]
36. Validation of a biotherapeutic immunoaffinity-LC-MS/MS assay in monkey serum: 'plug-and-play' across seven molecules.
Kaur S; Liu L; Cortes DF; Shao J; Jenkins R; Mylott WR; Xu K
Bioanalysis; 2016 Aug; 8(15):1565-1577. PubMed ID: 27396481
[TBL] [Abstract][Full Text] [Related]
37. The analysis of antipsychotic drugs in human matrices using LC-MS(/MS).
Saar E; Beyer J; Gerostamoulos D; Drummer OH
Drug Test Anal; 2012 Jun; 4(6):376-94. PubMed ID: 22573584
[TBL] [Abstract][Full Text] [Related]
38. Systematic evaluation of the root cause of non-linearity in liquid chromatography/tandem mass spectrometry bioanalytical assays and strategy to predict and extend the linear standard curve range.
Yuan L; Zhang D; Jemal M; Aubry AF
Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1465-74. PubMed ID: 22592990
[TBL] [Abstract][Full Text] [Related]
39. Antibody-free workflows for protein quantification by LC-MS/MS.
Wilffert D; Bischoff R; van de Merbel NC
Bioanalysis; 2015; 7(6):763-79. PubMed ID: 25871591
[TBL] [Abstract][Full Text] [Related]
40. Strategies for dealing with hemolyzed samples in regulated LC-MS/MS bioanalysis.
Tang D; Thomas E
Bioanalysis; 2012 Nov; 4(22):2715-24. PubMed ID: 23210654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
